FAMICORD AG - DE000A0BL849 (Stock)
Nasdaq OTC
Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
---|---|---|---|---|---|---|
4,75 USD
![]() |
5,0885% | 04.06.2025 15:50 | - | - | - | - |
Contact | |
---|---|
|
FamiCord AG Perlickstrasse 5 04103, Leipzig, DE |
Phone | +49-341-48792-5500 |
Fax | + |
info@famicord.com | |
Internet | http://www.famicord.com |
IR Contact/PR Contact | edicto GmbH/- |
Symbol | DE000A0BL849EUR |
End of financial year | 31.12.2025 |
Issued capital | 68.681.126,52 EUR |
Shareholders | |
---|---|
Active Ownership Capital SARL | 58,45% |
Freefloat | 22,55% |
Nationale-Nederlanden PTE SA | 9,10% |
Shareholder Value Beteiligungen AG | 5,40% |
Jakub Julian Baran | 3,56% |
Tomasz Franciszek Baran | 0,70% |
Knoesel & Ronge Vermögensverwaltung GmbH & Co. KG | 0,15% |
GVC Gaesco Gestión SGIIC SA | 0,09% |
Board | |
---|---|
Jakub Baran | Chairman of Managing Board |
Tomasz Baran | Member of Executive Committee |
Thomas Pfaadt | Member of Executive Committee |
Florian M. Schuhbauer | Chairman of Supervisory Board |
Konrad Adam Miterski | Member of Supervisory Board |
Frank Köhler | Member of Supervisory Board |
Dr. Ursula Schütze-Kreilkamp | Member of Supervisory Board |
Dr. Peter Greiner | Member of Supervisory Board |
Paul Owsianowski | Member of Supervisory Board |
Activity Description |
---|
FamiCord AG engages in the collection, logistics, processing, and storage of stem cells from umbilical cord blood, umbilical cord tissue, and other postnatal tissues, serving as a full-service provider for cryopreservation. It also engages in the development of products and drugs derived from cells, tissues, and blood for medical applications. Additionally, FamiCord is active in Cell & Gene therapies and operates as a CDMO. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany. |